Eventide Asset Management - ESSA PHARMA INC ownership

ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 21 filers reported holding ESSA PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ESSA PHARMA INC
ValueSharesWeighting
Q3 2022$2,841,000
-73.2%
1,561,251
-53.6%
0.06%
-75.3%
Q2 2022$10,602,000
-58.9%
3,365,568
-19.3%
0.23%
-43.8%
Q1 2022$25,772,000
-45.3%
4,170,259
+25.7%
0.40%
-32.9%
Q4 2021$47,125,000
+170.1%
3,318,647
+52.2%
0.60%
+161.7%
Q3 2021$17,449,000
-74.6%
2,181,101
-9.3%
0.23%
-75.1%
Q2 2021$68,716,000
-1.7%
2,405,1690.0%0.92%
-10.8%
Q1 2021$69,870,000
+164.0%
2,405,169
+3.0%
1.04%
+154.9%
Q4 2020$26,466,000
+72.9%
2,335,1690.0%0.41%
+35.3%
Q3 2020$15,307,000
+29.3%
2,335,169
+16.2%
0.30%
+16.7%
Q2 2020$11,840,000
+55.0%
2,010,1690.0%0.26%
+4.0%
Q1 2020$7,639,000
-27.3%
2,010,1690.0%0.25%
-16.6%
Q4 2019$10,503,000
+63.2%
2,010,1690.0%0.30%
+39.0%
Q3 2019$6,436,000
+99.6%
2,010,169
+45.1%
0.21%
+117.3%
Q2 2019$3,224,000
+95.0%
1,385,169
+187.4%
0.10%
+71.9%
Q1 2019$1,653,000
+63.3%
481,971
+0.0%
0.06%
+26.7%
Q4 2018$1,012,000
-32.3%
481,9700.0%0.04%
-18.2%
Q3 2018$1,494,000
-18.0%
481,970
-0.0%
0.06%
-27.6%
Q2 2018$1,822,000481,9710.08%
Other shareholders
ESSA PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 4,287,094$13,247,1201.22%
BVF INC/IL 8,748,629$27,033,2640.73%
PFM Health Sciences, LP 4,199,253$12,975,6920.61%
Bellevue Group AG 7,898,583$24,406,6210.39%
Rhenman & Partners Asset Management AB 356,500$1,101,5850.12%
Rock Springs Capital Management LP 677,005$2,091,9450.06%
Orbimed Advisors 842,366$2,602,9110.06%
Privium Fund Management (UK) Ltd 20,032$61,0980.05%
Hunting Hill Global Capital, LLC 10,000$30,9000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,042,531$3,221,4210.01%
View complete list of ESSA PHARMA INC shareholders